UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Chubb
CB
|
+$745M |
| 2 |
Spotify
SPOT
|
+$727M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$689M |
| 4 |
Meta Platforms (Facebook)
META
|
+$680M |
| 5 |
NXP Semiconductors
NXPI
|
+$573M |
Top Sells
| 1 |
Prologis
PLD
|
+$1.33B |
| 2 |
Union Pacific
UNP
|
+$1.2B |
| 3 |
Equinix
EQIX
|
+$929M |
| 4 |
Broadcom
AVGO
|
+$805M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| 1 | Technology | 37.43% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
iShares Core US Aggregate Bond ETF
AGG
$138B
| $561K | ﹤0.01% |
+5,617
| New | +$564K |
|
2302
Realty Income
O
$59.8B
| $552K | ﹤0.01% |
9,784
-20,003
| -67% | -$1.16M |
|
2303
ASP Isotopes
ASPI
$578M
| $548K | ﹤0.01% |
+102,376
| New | +$814K |
|
2304
SkyWater Technology
SKYT
$1.57B
| $538K | ﹤0.01% |
+29,616
| New | +$515K |
|
2305
NatWest
NWG
$69.6B
| $531K | ﹤0.01% |
30,346
-1,146,325
| -97% | -$18.2M |
|
2306
Willis Lease Finance
WLFC
$1.72B
| $531K | ﹤0.01% |
3,915
| – | – |
|
2307
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $524K | ﹤0.01% |
+5,568
| New | +$525K |
|
2308
Polestar Automotive Holding UK
PSNY
$2.61B
| $522K | ﹤0.01% |
+24,450
| New | +$510K |
|
2309
iShares Russell 2000 ETF
IWM
$82B
| $519K | ﹤0.01% |
+2,108
| New | +$518K |
|
2310
Akebia Therapeutics
AKBA
$370M
| $515K | ﹤0.01% |
319,797
-7,162
| -2% | -$15K |
|
2311
Inter&Co
INTR
$2.49B
| $513K | ﹤0.01% |
+60,500
| New | +$535K |
|
2312
Phathom Pharmaceuticals
PHAT
$870M
| $508K | ﹤0.01% |
+30,631
| New | +$437K |
|
2313
Bilibili
BILI
$7.36B
| $506K | ﹤0.01% |
+20,585
| New | +$554K |
|
2314
Tiptree Inc
TIPT
$678M
| $505K | ﹤0.01% |
27,618
+90
| +0.3% | +$1.64K |
|
2315
Skillsoft
SKIL
$63.5M
| $504K | ﹤0.01% |
54,238
| – | – |
|
|
VOYG
2316
Voyager Technologies
VOYG
$1.76B
| $502K | ﹤0.01% |
+19,200
| New | +$521K |
|
2317
Dianthus Therapeutics
DNTH
$5.39B
| $498K | ﹤0.01% |
+12,073
| New | +$468K |
|
2318
Cullinan Oncology
CGEM
$1.1B
| $497K | ﹤0.01% |
48,051
+888
| +2% | +$8.01K |
|
2319
Gerdau
GGB
$8.81B
| $495K | ﹤0.01% |
134,021
-1,856,859
| -93% | -$6.49M |
|
2320
Frontier Group Holdings
ULCC
$1.51B
| $494K | ﹤0.01% |
104,921
| – | – |
|
2321
Bumble
BMBL
$406M
| $489K | ﹤0.01% |
136,950
-2,819
| -2% | -$12.5K |
|
2322
JPMorgan BetaBuilders Europe ETF
BBEU
$9.09B
| $487K | ﹤0.01% |
+6,641
| New | +$472K |
|
2323
Capital City Bank Group
CCBG
$849M
| $482K | ﹤0.01% |
11,329
+119
| +1% | +$4.96K |
|
2324
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $482K | ﹤0.01% |
+4,973
| New | +$479K |
|
2325
Ginkgo Bioworks
DNA
$591M
| $480K | ﹤0.01% |
57,736
+60
| +0.1% | +$646 |
|
Similar funds
